TKM-Marburg

N/A

Report date: 2022/12/08 15:04:58
NME

Base Information

Drug NameTKM-Marburg
Drug Alias NameTKM-ALDHTKM-HTGTKM-GSDWEE1/CSN5ARB 270729 +[6] 
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionCOP9 signalosome complex subunit 5 inhibitorsSerine/threonine-protein kinase WEE1 inhibitorsRNA interference
TargetsCOP9 signalosome complex subunit 5Serine/threonine-protein kinase WEE1
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesProtiva BiotherapeuticsArbutus Biopharma CorpUniversity Of Texas Medical Branch
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesProtiva BiotherapeuticsArbutus Biopharma CorpUniversity Of Texas Medical Branch
Active IndicationsN/A
Inactive IndicationsHepatitis B

Other Information

ATC CodeN/A
Related LinksN/A